In this work, we demonstrate that a combined treatment approach consisting of suppressed p190RhoGAP expression (leading to constantly increased activity of RhoA) into tumours and inactivation of p110δ PI3K in macrophages blocks melanoma and SCC progression. This evidence concerns the gene RHOA and neoplasm.